A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Tango Therapeutics, Inc.
Merck Sharp & Dohme LLC
Parabilis Medicines, Inc.
Tango Therapeutics, Inc.
STORM Therapeutics LTD
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
ModeX Therapeutics, An OPKO Health Company
Eli Lilly and Company
USWM, LLC (dba US WorldMeds)
Lantheus Medical Imaging
Deciphera Pharmaceuticals, LLC
Jazz Pharmaceuticals
Haihe Biopharma Co., Ltd.
Adcendo ApS
Eli Lilly and Company
Perspective Therapeutics
Ocellaris Pharma, Inc.
Eli Lilly and Company
iOmx Therapeutics AG
Tanabe Pharma America, Inc.
Eli Lilly and Company
Sotio Biotech Inc.
Transgene
Turning Point Therapeutics, Inc.
Stella Pharma Corporation
Shasqi, Inc.
GlaxoSmithKline
Ipsen
ImmVira Pharma Co. Ltd
BioAtla, Inc.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Sensei Biotherapeutics, Inc.
Lantheus Medical Imaging
Ascentage Pharma Group Inc.
Incyte Corporation
PharmaMar
Lamassu Bio Inc
OncoC4, Inc.
ImmunoGenesis
Hutchmed
MedPacto, Inc.
Intensity Therapeutics, Inc.
Ascentage Pharma Group Inc.
ImmunityBio, Inc.
Cogent Biosciences, Inc.
Oncternal Therapeutics, Inc
BeiGene
Cybrexa Therapeutics